59 related articles for article (PubMed ID: 2250943)
1. [Role of growth hormone in proliferative diabetic retinopathy. Clinical and immunohistochemical aspects].
Negre F; Fredj-Reygrobellet D; Harroche S; Taieb JC
Ophtalmologie; 1990; 4(1):56-9. PubMed ID: 2250943
[TBL] [Abstract][Full Text] [Related]
2. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
[TBL] [Abstract][Full Text] [Related]
3. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
4. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
[TBL] [Abstract][Full Text] [Related]
5. [Significance and detection of insulin-like growth factor I in vitreous with proliferative retinal diseases by radioimmunoassay].
Cao J; Wu L; Zhang H
Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):122-5. PubMed ID: 7656720
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
7. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
Gacka M; Adamiec J
Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
Loukovaara S; Immonen IJ; Koistinen R; Rutanen EM; Hiilesmaa V; Loukovaara M; Kaaja RJ
J Diabetes Complications; 2005; 19(5):297-304. PubMed ID: 16112506
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
10. [Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy].
Asensio-Sánchez VM; Gómez-Ramírez V; Morales-Gómez I
Arch Soc Esp Oftalmol; 2008 Mar; 83(3):169-72. PubMed ID: 18311675
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes.
Ulbig MW; Wolfensberger TJ; Hiscott P; Ationu A; Carter ND; Gregor ZJ
Ger J Ophthalmol; 1995 Sep; 4(5):264-8. PubMed ID: 7496335
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-1 levels in diabetic proliferative retinopathy.
Hopkins KD; Brart DO; Russell-Jones DL; Chignell AH; Sönksen PH
Horm Metab Res; 1993 Jun; 25(6):331-2. PubMed ID: 7688338
[No Abstract] [Full Text] [Related]
13. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
14. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
[TBL] [Abstract][Full Text] [Related]
15. The growth hormone hypothesis - 2005 revision.
Frystyk J
Horm Metab Res; 2005 Apr; 37 Suppl 1():44-8. PubMed ID: 15918110
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
Zhou H; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
[TBL] [Abstract][Full Text] [Related]
17. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
20. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Liinamaa MJ; Savolainen MJ
Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
